US 10344033
2-aminoquinazoline derivatives as P70S6 kinase inhibitors
granted A61PA61P25/28A61P35/04
Quick answer
US patent 10344033 (2-aminoquinazoline derivatives as P70S6 kinase inhibitors) held by SENTINEL ONCOLOGY LIMITED expires Mon Jul 04 2039 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- SENTINEL ONCOLOGY LIMITED
- Grant date
- Tue Jul 09 2019 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Jul 04 2039 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 20
- CPC classes
- A61P, A61P25/28, A61P35/04